232 related articles for article (PubMed ID: 10628302)
1. Measurement of in vivo sunscreen immune protection factors in humans.
Damian DL; Barnetson RS; Halliday GM
Photochem Photobiol; 1999 Dec; 70(6):910-5. PubMed ID: 10628302
[TBL] [Abstract][Full Text] [Related]
2. Broad-spectrum sunscreens provide greater protection against ultraviolet-radiation-induced suppression of contact hypersensitivity to a recall antigen in humans.
Damian DL; Halliday GM; Barnetson RS
J Invest Dermatol; 1997 Aug; 109(2):146-51. PubMed ID: 9242499
[TBL] [Abstract][Full Text] [Related]
3. Broad-spectrum sunscreens provide better protection from solar ultraviolet-simulated radiation and natural sunlight-induced immunosuppression in human beings.
Moyal DD; Fourtanier AM
J Am Acad Dermatol; 2008 May; 58(5 Suppl 2):S149-54. PubMed ID: 18410801
[TBL] [Abstract][Full Text] [Related]
4. Sunscreens prevent local and systemic immunosuppression of contact hypersensitivity in mice exposed to solar-simulated ultraviolet radiation.
Roberts LK; Beasley DG
J Photochem Photobiol B; 1997 Jun; 39(2):121-9. PubMed ID: 9225458
[TBL] [Abstract][Full Text] [Related]
5. Age and gender effects on contact sensitization and photoimmune suppression in young and middle-aged adults.
Morrissey K; Xue W; Cooper K; Baron E
Photodermatol Photoimmunol Photomed; 2008 Feb; 24(1):46-8. PubMed ID: 18201358
[TBL] [Abstract][Full Text] [Related]
6. Topical nicotinamide modulates cellular energy metabolism and provides broad-spectrum protection against ultraviolet radiation-induced immunosuppression in humans.
Sivapirabu G; Yiasemides E; Halliday GM; Park J; Damian DL
Br J Dermatol; 2009 Dec; 161(6):1357-64. PubMed ID: 19804594
[TBL] [Abstract][Full Text] [Related]
7. Sunscreens containing the broad-spectrum UVA absorber, Mexoryl SX, prevent the cutaneous detrimental effects of UV exposure: a review of clinical study results.
Fourtanier A; Moyal D; Seité S
Photodermatol Photoimmunol Photomed; 2008 Aug; 24(4):164-74. PubMed ID: 18717957
[TBL] [Abstract][Full Text] [Related]
8. Effect of daily versus intermittent sunscreen application on solar simulated UV radiation-induced skin response in humans.
Phillips TJ; Bhawan J; Yaar M; Bello Y; Lopiccolo D; Nash JF
J Am Acad Dermatol; 2000 Oct; 43(4):610-8. PubMed ID: 11004615
[TBL] [Abstract][Full Text] [Related]
9. Prevention of UVB-induced immunosuppression in humans by a high sun protection factor sunscreen.
Whitmore SE; Morison WL
Arch Dermatol; 1995 Oct; 131(10):1128-33. PubMed ID: 7574828
[TBL] [Abstract][Full Text] [Related]
10. Ultraviolet spectral energy differences affect the ability of sunscreen lotions to prevent ultraviolet-radiation-induced immunosuppression.
Roberts LK; Beasley DG; Learn DB; Giddens LD; Beard J; Stanfield JW
Photochem Photobiol; 1996 Jun; 63(6):874-84. PubMed ID: 8992508
[TBL] [Abstract][Full Text] [Related]
11. Low-dose UVA and UVB have different time courses for suppression of contact hypersensitivity to a recall antigen in humans.
Damian DL; Barnetson RS; Halliday GM
J Invest Dermatol; 1999 Jun; 112(6):939-44. PubMed ID: 10383742
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of a broad-spectrum sunscreen to protect engineered human skin from tissue and DNA damage induced by solar ultraviolet exposure.
Bissonauth V; Drouin R; Mitchell DL; Rhainds M; Claveau J; Rouabhia M
Clin Cancer Res; 2000 Oct; 6(10):4128-35. PubMed ID: 11051266
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppression induced by acute solar-simulated ultraviolet exposure in humans: prevention by a sunscreen with a sun protection factor of 15 and high UVA protection.
Serre I; Cano JP; Picot MC; Meynadier J; Meunier L
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 1):187-94. PubMed ID: 9270502
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of systemic immune suppression by UV irradiation in vivo. II. The UV effects on number and morphology of epidermal Langerhans cells and the UV-induced suppression of contact hypersensitivity have different wavelength dependencies.
Noonan FP; Bucana C; Sauder DN; De Fabo EC
J Immunol; 1984 May; 132(5):2408-16. PubMed ID: 6232317
[TBL] [Abstract][Full Text] [Related]
15. Effects of low-dose ultraviolet radiation on in vivo human cutaneous recall responses.
Damian DL; Barnetson RS; Halliday GM
Australas J Dermatol; 2001 Aug; 42(3):161-7. PubMed ID: 11488707
[TBL] [Abstract][Full Text] [Related]
16. Immune protection factors of chemical sunscreens measured in the local contact hypersensitivity model in humans.
Wolf P; Hoffmann C; Quehenberger F; Grinschgl S; Kerl H
J Invest Dermatol; 2003 Nov; 121(5):1080-7. PubMed ID: 14708610
[TBL] [Abstract][Full Text] [Related]
17. High ultraviolet A protection affords greater immune protection confirming that ultraviolet A contributes to photoimmunosuppression in humans.
Baron ED; Fourtanier A; Compan D; Medaisko C; Cooper KD; Stevens SR
J Invest Dermatol; 2003 Oct; 121(4):869-75. PubMed ID: 14632207
[TBL] [Abstract][Full Text] [Related]
18. Partial protection against epidermal IL-10 transcription and Langerhans cell depletion by sunscreens after exposure of human skin to UVB.
Hochberg M; Enk CD
Photochem Photobiol; 1999 Nov; 70(5):766-72. PubMed ID: 10568168
[TBL] [Abstract][Full Text] [Related]
19. The topical isoflavonoid NV-07alpha reduces solar-simulated UV-induced suppression of Mantoux reactions in humans.
Friedmann AC; Halliday GM; Barnetson RS; Reeve VE; Walker C; Patterson CR; Damian DL
Photochem Photobiol; 2004; 80(3):416-21. PubMed ID: 15623323
[TBL] [Abstract][Full Text] [Related]
20. Broad-spectrum sunscreens provide better protection from the suppression of the elicitation phase of delayed-type hypersensitivity response in humans.
Moyal DD; Fourtanier AM
J Invest Dermatol; 2001 Nov; 117(5):1186-92. PubMed ID: 11710931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
